Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORA | P35398 | 1/20 | 0.39 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | RORB | Q92753 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 2/20 | 0.35 |
| ▸ | TSPO | P30536 | 3/20 | 0.34 |
| ▸ | LPL | P06858 | 2/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ICMT | O60725 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8739908 | 0.89 | RORA (0.46) | RORARORCRORBDHFRLPL | |
| SCHEMBL26048120 | 0.88 | KDM4E (0.43) | RORARORCRORBTSPOCNR2 | |
| SCHEMBL16151832 | 0.86 | TSPO (0.42) | RORARORCRORBTSPOCNR2 | |
| SCHEMBL8739909 | 0.86 | KDM4E (0.43) | PPARGKDM4EATML3MBTL1 | |
| SCHEMBL14849242 | 0.84 | KDM4E (0.33) | TSPOKDM4EATML3MBTL1 | |
| SCHEMBL23072562 | 0.84 | RORA (0.34) | RORARORCRORBDHFRCNR2 | |
| SCHEMBL24914710 | 0.84 | TSPO (0.43) | RORARORCRORBTSPOCNR2 | |
| SCHEMBL29328807 | 0.82 | HSD11B1 (0.45) | RORARORCRORBTSPOICMT | |
| SCHEMBL10108429 | 0.82 | TSPO (0.39) | RORARORCRORBTSPOKDM4E | |
| SCHEMBL8739896 | 0.81 | KDM4E (0.41) | RORARORCRORBTSPOCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171293-B2 | Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element | UDC IRELAND LIMITED (IE) | 2021-11-09 | — | — | US | disclosed |
| US-10297760-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | UDC IRELAND LIMITED (IE) | 2019-05-21 | — | — | US | disclosed |
| US-20180102483-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | UDC IRELAND LTD (IE) | 2018-04-12 | — | — | US | disclosed |
| US-9812650-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | UDC IRELAND LIMITED (IE) | 2017-11-07 | — | — | US | disclosed |
| US-9608207-B2 | Organic electroluminescence element | UDC IRELAND LIMITED (IE) | 2017-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10297760-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | RPS10, RPS20, RPS19 | RORA 219/4885RORC 488/4885RORB 275/4885 |
| US-20180102483-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | RPS10, RPS20, RPS19 | RORA 219/4885RORC 488/4885RORB 275/4885 |
| US-11171293-B2 | Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element | L1CAM, OR10J3, INTS9 | RORA 187/4885RORC 584/4885RORB 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.